| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |